» Articles » PMID: 34120487

Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies

Overview
Specialty Endocrinology
Date 2021 Jun 14
PMID 34120487
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Conventional home blood glucose measurements require a sample of blood that is obtained by puncturing the skin at the fingertip. To avoid the pain associated with this procedure, there is high demand for medical products that allow glucose monitoring without blood sampling. In this review article, all such products are presented.

Methods: In order to identify such products, four different sources were used: (1) PubMed, (2) Google Patents, (3) Diabetes Technology Meeting Startup Showcase participants, and (4) experts in the field of glucose monitoring. The information obtained were filtered by using two inclusion criteria: (1) regulatory clearance, and/or (2) significant coverage in Google News starting in the year 2016, unless the article indicated that the product had been discontinued. The identified bloodless monitoring products were classified into three categories: (1) noninvasive optical, (2) noninvasive fluid sampling, and (3) minimally invasive devices.

Results: In total, 28 noninvasive optical, 6 noninvasive fluid sampling, and 31 minimally invasive glucose monitoring products were identified. Subsequently, these products were characterized according to their regulatory, technological, and consumer features. Products with regulatory clearance are described in greater detail according to their advantages and disadvantages, and with design images.

Conclusions: Based on favorable technological features, consumer features, and other advantages, several bloodless products are commercially available and promise to enhance diabetes management. Paths for future products are discussed with an emphasis on understanding existing barriers related to both technical and non-technical issues.

Citing Articles

Additively manufactured microwave sensor for glucose level detection in saliva.

Piekarz I, Skarzynski K, Piekarz B, Wincza K, Gruszczynski S, Sloma M Sci Rep. 2024; 14(1):28235.

PMID: 39548327 PMC: 11568311. DOI: 10.1038/s41598-024-79867-1.


Development of a target product profile for new glucose self-monitoring technologies for use in low- and middle-income countries.

Safary E, Lepeska M, Beran D, Ewen M, Zhaparova A, Rukare J PLoS One. 2024; 19(8):e0309062.

PMID: 39186719 PMC: 11346918. DOI: 10.1371/journal.pone.0309062.


Review of Microwave Near-Field Sensing and Imaging Devices in Medical Applications.

Origlia C, Rodriguez-Duarte D, Tobon Vasquez J, Bolomey J, Vipiana F Sensors (Basel). 2024; 24(14).

PMID: 39065913 PMC: 11280878. DOI: 10.3390/s24144515.


Implementation research: a protocol for two three-arm pragmatic randomised controlled trials on continuous glucose monitoring devices in people with type 1 diabetes in South Africa and Kenya.

Marban-Castro E, Muhwava L, Kamau Y, Safary E, Rheeder P, Karsas M Trials. 2024; 25(1):331.

PMID: 38773658 PMC: 11107040. DOI: 10.1186/s13063-024-08132-7.


Noninvasive Diabetes Detection through Human Breath Using TinyML-Powered E-Nose.

Gudino-Ochoa A, Garcia-Rodriguez J, Ochoa-Ornelas R, Cuevas-Chavez J, Sanchez-Arias D Sensors (Basel). 2024; 24(4).

PMID: 38400451 PMC: 10891698. DOI: 10.3390/s24041294.


References
1.
Svedman C, Ulriksdotter J, Lejding T, Bruze M, Mowitz M . Changes in adhesive ingredients in continuous glucose monitoring systems may induce new contact allergy pattern. Contact Dermatitis. 2021; 84(6):439-446. DOI: 10.1111/cod.13781. View

2.
Tamada J, Garg S, Jovanovic L, Pitzer K, Fermi S, Potts R . Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. JAMA. 1999; 282(19):1839-44. DOI: 10.1001/jama.282.19.1839. View

3.
Jina A, Tierney M, Tamada J, McGill S, Desai S, Chua B . Design, development, and evaluation of a novel microneedle array-based continuous glucose monitor. J Diabetes Sci Technol. 2014; 8(3):483-7. PMC: 4455438. DOI: 10.1177/1932296814526191. View

4.
Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A . Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014; (2):CD009122. PMC: 6486147. DOI: 10.1002/14651858.CD009122.pub2. View

5.
do Amaral C, Wolf B . Current development in non-invasive glucose monitoring. Med Eng Phys. 2007; 30(5):541-9. DOI: 10.1016/j.medengphy.2007.06.003. View